CARDLYTICS INC's ticker is and the CUSIP is 14161WAB1. A total of 11 filers reported holding CARDLYTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 11,025,000 | $6,174,000 | 0.44% |
| LINDEN ADVISORS LP | 58,112,000 | $32,198,406 | 0.34% |
| WOLVERINE ASSET MANAGEMENT LLC | 33,928,000 | $19,223,693 | 0.23% |
| Teton Advisors, Inc. | 780,000 | $443,539 | 0.12% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 20,160,000 | $11,366,208 | 0.06% |
| GABELLI FUNDS LLC | 4,560,000 | $2,592,998 | 0.02% |
| Citadel Advisors | 86,195,000 | $48,755,167 | 0.01% |
| GAMCO INVESTORS, INC. ET AL | 300,000 | $170,592 | 0.00% |
| ROYAL BANK OF CANADA | 7,883,000 | $4,434,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 2,583,000 | $1,438,071 | 0.00% |
This page lists CARDLYTICS INC's shareholders in Q2 2023. To view CARDLYTICS INC's shareholder history, click here.